BioCentury
ARTICLE | Clinical News

ARG201 regulatory update

December 22, 2008 8:00 AM UTC

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for ARG201 to treat systemic sclerosis. arGentis has completed a Phase II trial of the ...